A Review of EGFR-TKIs Therapy of Non-small Cell Lung Cancer 
with Uncommon EGFR Mutations

This article reviews the efficacy of EGFR-TKIs in patients with uncommon EGFR mutations, and give some reasonable advice about the selection of treatments for patients with NSCLC who harbor uncommon EGFR mutations. DOI: 10.3779/j.issn.1009-3419.2019.09.07
Source: Chinese Journal of Lung Cancer - Category: Cancer & Oncology Source Type: research